U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C30H39FN4O4.ClH.H2O
Molecular Weight 593.13
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ULIMORELIN HYDROCHLORIDE

SMILES

O.Cl.C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](CC3=CC=C(F)C=C3)C(=O)NCCCC4=C(O1)C=CC=C4

InChI

InChIKey=ZWIXEQBDJMFCMN-DHHNQDMHSA-N
InChI=1S/C30H39FN4O4.ClH.H2O/c1-19-18-33-27(23-12-13-23)30(38)35(3)20(2)28(36)34-25(17-21-10-14-24(31)15-11-21)29(37)32-16-6-8-22-7-4-5-9-26(22)39-19;;/h4-5,7,9-11,14-15,19-20,23,25,27,33H,6,8,12-13,16-18H2,1-3H3,(H,32,37)(H,34,36);1H;1H2/t19-,20-,25-,27+;;/m1../s1

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C30H39FN4O4
Molecular Weight 538.6535
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Ulimorelin (TZP101) is a small molecule, intravenously administered, ghrelin receptor agonist that is being developed by Lyric Pharmaceuticals. Ulimorelin stimulates intestinal motility, but also reduces blood pressure in rodents and humans and dilates blood vessels. It has been proposed as a treatment for intestinal motility disorders. Ulimorelin has progressed to phase III human clinical trials for the treatment of postoperative ileus.

Approval Year

PubMed

PubMed

TitleDatePubMed
Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic.
2011 Dec 22
The mechanism of enhanced defecation caused by the ghrelin receptor agonist, ulimorelin.
2014 Feb
Analysis of the ghrelin receptor-independent vascular actions of ulimorelin.
2015 Apr 5
Patents

Sample Use Guides

Partial bowel resection: Thirty-minute intravenous infusions (160 ug/kg, 480 ug/kg ulimorelin, or placebo) once daily were started within 60 minutes after the end of surgery and ended at the first of the following: primary efficacy end point fulfilled (defined below), hospital discharge, or 7 days treatment.
Route of Administration: Intravenous
Ulimorelin (0.03-30uM) inhibited phenylephrine-induced contractions of rat saphenous (IC50=0.6uM; Imax=66±5%; n=3-6) and mesenteric arteries (IC50=5uM, Imax=113±16%; n=3-4). In mesenteric arteries, ulimorelin, 1-10uM, caused a surmountable rightward shift in the response to phenylephrine (0.01-1000uM; pA2=5.7; n=3-4). Ulimorelin is an agonist of G-protein coupled receptor (Ki=16 nM, EC50=29 nM).
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:35:18 GMT 2023
Edited
by admin
on Fri Dec 15 18:35:18 GMT 2023
Record UNII
662MCS79XH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ULIMORELIN HYDROCHLORIDE
USAN  
USAN  
Official Name English
(2R,5S,8R,11R)-5-CYCLOPROPYL-11-((4-FLUOROPHENYL)METHYL)-2,7,8-TRIMETHYL- 2,3,4,5,7,8,10,11,13,14,15,16-DODECAHYDRO-6H-1,4,7,10,13- BENZOXATETRAAZACYCLOOCTADECINE-6,9,12-TRIONE HYDROCHLORIDE MONOHYDRATE
Systematic Name English
ULIMORELIN HYDROCHLORIDE MONOHYDRATE
MI   WHO-DD  
Common Name English
2H-1,4,7,10,13-BENZOXATETRAAZACYCLOOCTADECINE-6,9,12(3H)-TRIONE, 5-CYCLOPROPYL-11-((4-FLUOROPHENYL)METHYL)-4,5,7,8,10,11,13,14,15,16-DECAHYDRO-2,7,8-TRIMETHYL-, HYDROCHLORIDE, HYDRATE (1:1:1), (2R,5S,8R,11R)-
Common Name English
Ulimorelin hydrochloride monohydrate [WHO-DD]
Common Name English
ULIMORELIN HYDROCHLORIDE MONOHYDRATE [MI]
Common Name English
ULIMORELIN HYDROCHLORIDE [USAN]
Common Name English
TZP-101
Code English
Classification Tree Code System Code
NCI_THESAURUS C78276
Created by admin on Fri Dec 15 18:35:18 GMT 2023 , Edited by admin on Fri Dec 15 18:35:18 GMT 2023
Code System Code Type Description
USAN
WW-61
Created by admin on Fri Dec 15 18:35:18 GMT 2023 , Edited by admin on Fri Dec 15 18:35:18 GMT 2023
PRIMARY
CAS
951326-02-6
Created by admin on Fri Dec 15 18:35:18 GMT 2023 , Edited by admin on Fri Dec 15 18:35:18 GMT 2023
PRIMARY
EPA CompTox
DTXSID70241766
Created by admin on Fri Dec 15 18:35:18 GMT 2023 , Edited by admin on Fri Dec 15 18:35:18 GMT 2023
PRIMARY
EVMPD
SUB121120
Created by admin on Fri Dec 15 18:35:18 GMT 2023 , Edited by admin on Fri Dec 15 18:35:18 GMT 2023
PRIMARY
PUBCHEM
56841653
Created by admin on Fri Dec 15 18:35:18 GMT 2023 , Edited by admin on Fri Dec 15 18:35:18 GMT 2023
PRIMARY
NCI_THESAURUS
C102755
Created by admin on Fri Dec 15 18:35:18 GMT 2023 , Edited by admin on Fri Dec 15 18:35:18 GMT 2023
PRIMARY
MERCK INDEX
m11299
Created by admin on Fri Dec 15 18:35:18 GMT 2023 , Edited by admin on Fri Dec 15 18:35:18 GMT 2023
PRIMARY Merck Index
DRUG BANK
DBSALT002140
Created by admin on Fri Dec 15 18:35:18 GMT 2023 , Edited by admin on Fri Dec 15 18:35:18 GMT 2023
PRIMARY
SMS_ID
300000048017
Created by admin on Fri Dec 15 18:35:18 GMT 2023 , Edited by admin on Fri Dec 15 18:35:18 GMT 2023
PRIMARY
ChEMBL
CHEMBL1963249
Created by admin on Fri Dec 15 18:35:18 GMT 2023 , Edited by admin on Fri Dec 15 18:35:18 GMT 2023
PRIMARY
FDA UNII
662MCS79XH
Created by admin on Fri Dec 15 18:35:18 GMT 2023 , Edited by admin on Fri Dec 15 18:35:18 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
ANHYDROUS->SOLVATE
Related Record Type Details
ACTIVE MOIETY